I
schemic heart disease is a major component of cardiovascular disease and a leading cause of death worldwide. 1, 2 Although much progress has been made in understanding the causes of ischemic heart disease, the molecular underpinnings that occur during ischemia/reperfusion (I/R) injury have not yet been fully elucidated, and the result is current treatments that are only partially effective.
Mammalian sterile 20-like kinase 1 (Mst1) is a ubiquitously expressed and highly conserved serine/threonine kinase 3 that is activated in the heart during stress conditions including I/R, myocardial infarction, and pressure overload. [4] [5] [6] Previous work from our group has shown that suppression of Mst1 inhibits I/R injury 4, 7 and prevents cardiac remodeling/ dysfunction after chronic myocardial infarction, 5 suggesting that Mst1 is a promising target of cardiac therapy for ischemic heart disease. Mst1 is the mammalian homolog of Drosophila hippo and the centerpiece of a signaling cascade that culminates in the phosphorylation and inactivation of the transcriptional cofactor yorkie [mammalian Yes-associated protein (Yap)]. Our recent work demonstrated Yap to be a critical transcriptional cofactor that mediates cardioprotection and homeostasis of the adult heart.
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signals through, effector proteins. NF2 structure is regulated by phosphorylation at Ser518, 15 a site that can be phosphorylated by PAK2 16, 17 and PKA, 18 and dephosphorylated by the myosin light chain phosphatase, MYPT-1. 19 When Ser518 is phosphorylated, NF2 assumes an open conformation and can no longer associate with binding partners, effectively inhibiting its function. 15, [20] [21] [22] Conversely, dephosphorylation of NF2 favors a closed conformation that promotes protein interaction and signal transduction. Studies in Drosophila have provided evidence that NF2 can regulate the activity of hippo/yorkie, thereby modulating cell proliferation and survival. [23] [24] [25] Yet, to date, evidence linking NF2 and Mst1/Yap in mammalian systems is limited. [26] [27] [28] Herein, we demonstrate that NF2 is activated by oxidative stress through dephosphorylation by the protein phosphatasetargeting subunit MYPT-1. Active NF2 promotes cardiomyocyte apoptosis through the activation of Mst1 and the engagement of the Hippo signaling pathway. Interestingly, NF2 is present in the cytosol and nuclei of cardiomyocytes and promotes phosphorylation and inactivation of Yap, thereby attenuating Yap target gene expression. Mice deficient for NF2 in cardiomyocytes (NF2 flox/flox ;Cre αMHC ; NF2 cardiomyocyte-specific knockout) show diminished Mst1 activation, increased Yap transcriptional activity, and are protected against I/R injury. These results provide evidence that NF2 modulates Hippo signaling in the mammalian heart to promote acute myocardial injury.
Methods
An expanded Methods section is available in the online Data Supplement.
Animal Models
NF2-floxed mice 29 were crossed with α-MHC (alpha myosin heavy chain)-Cre transgenic mice 30 to generate cardiac-specific knockout (NF2 CKO) mice. Yap-floxed mice 26 were bred to NF2 CKO mice to generate NF2 ;Cre αMHC mice. Mice were housed in a temperature-controlled environment with 12-hour light/dark cycles where they received food and water ad libitum. All protocols concerning the use of animals were approved by the Institutional Animal Care and Use Committee at Rutgers, The State University of New Jersey.
Statistics
All data are reported as mean±SEM. Evaluation between ≥3 groups was done using one-way ANOVA. The statistical significance of the differences between groups was calculated using post hoc comparisons. Student t test was used to evaluate the difference in means between two groups. Statistical analyses were performed using Graph Pad Prism 6.0. A P<0.05 was considered significant.
Results

Regulation of NF2 by Oxidative Stress
Our previous work demonstrated that Mst1 is activated in response to oxidative stress both in cultured cardiomyocytes and mouse myocardium in vivo. 7, 31 Therefore, we first determined the activation status of NF2 using Ser518 phosphorylation as an indicator of the inactive conformation of NF2. Treatment of neonatal rat ventricular myocytes (NRVMs) with H 2 O 2 , to mimic oxidative stress during reperfusion, elicited the activation of both NF2 and Mst1 ( Figure 1A through 1C) . To test the activation of NF2 in vivo, we subjected wild-type C57BL/6 mice to I/R and performed Western blots to assay phosphorylation status. Similarly, we found that both NF2 and Mst1 were activated in the myocardium by I/R ( Figure 1D and 1F). We also evaluated the samples of failing human hearts and observed increased NF2 and Mst1 activation compared with healthy controls (Online Figure I) . Because NF2 phosphorylation is decreased in response to oxidative stress, it is possible that increased phosphatase activity is responsible. To test this, we pretreated NRVMs with the phosphatase inhibitors okadaic acid or calyculin A, followed by stimulation with H 2 O 2 . The dephosphorylation of NF2 caused by H 2 O 2 was partially attenuated in okadaic acid-treated cells at high concentration, but was fully prevented in calyculin A-treated cells indicating likely involvement of PP1 phosphatase (Online Figure II) . Previous work identified PP1δ-MYPT-1 as an activator of NF2 through dephosphorylation of Ser518 in mammalian cells 19, 32 and in Drosophila. 33 A lack of phosphorylation of MYPT-1 at Ser696 is indicative of its activation. We observed decreased MYPT-1 phosphorylation in response to oxidative stress both in NRVMs and mouse myocardium ( Figure 1G through 1J) . To directly test the involvement of MYPT-1 in NF2 regulation, we depleted NRVMs of endogenous MYPT-1 using siRNA. MYPT-1 downregulation was sufficient to attenuate NF2 activation by oxidative stress ( Figure 1K ). Taken together, these data indicate that MYPT-1 is activated by oxidative stress and mediates the dephosphorylation and activation of NF2 in cardiomyocytes.
NF2 Promotes Mst1 Activation and Cardiomyocyte Apoptosis
NF2 can activate the Hippo pathway in the liver 26 and brain. 27 We sought to determine whether NF2 regulates Hippo signaling in the adult heart. Overexpression of NF2 in NRVMs stimulated Mst1 activation (Figure 2A and B). Mst1 is known to promote cell death; therefore, we evaluated cardiomyocyte apoptosis in response to NF2. We found that increased NF2 expression caused a significant increase in terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cardiomyocytes and that this response was significantly attenuated by the inhibition of Mst1 ( Figure 2C and 2D) . Similarly, NF2 elicited caspase-3 activation, which was significantly reduced by the inhibition of Mst1 ( Figure 2E and 2F). On the contrary, knockdown of endogenous NF2 using siRNA attenuated both the activation of Mst1 and cardiomyocyte apoptosis driven by H 2 O 2 ( Figure 2G and 2H 
Subcellular Localization of NF2 in Cardiomyocytes
Previous work has demonstrated subcellular localization of NF2 at tight junctions, 34 adherens junctions, 35 desmosomes, 28 the plasma membrane, 36 and in the nucleus. 37 We sought to investigate the localization of NF2 in NRVMs. Confocal imaging revealed the distribution of NF2 in the cytosol, at the cell membrane, and a strong nuclear signal in NRVMs ( Figure  3A , Online Figure IIIA) . Detection of p-NF2 revealed a diffuse cytosolic and nuclear distribution with a relatively more pronounced presence at the plasma membrane (Online Figure  IIIB) . We also stained mouse heart sections and observed both nuclear and cytosolic localization of NF2 (Online Figure  IVA) . As a control, we evaluated HEK293 cells and found predominant plasma membrane distribution of NF2 and no appreciable nuclear signal (Online Figure IIIC) . To investigate this biochemically, we separated mouse ventricular lysates into cytosolic and nuclear-enriched fractions. We detected endogenous NF2 and p-NF2 in both fractions ( Figure 3B ).
Similarly, NF2 was observed in cytosolic and nuclear-enriched fractions generated from NRVMs and isolated adult mouse cardiomyocytes ( Figure 3C ; Online Figure IVB) . Although p-NF2 was detected in cytosolic and nuclear-enriched fractions of NRVMs, we did not observe an appreciable change in p-NF2 levels in the cytosol after H 2 O 2 treatment, whereas nuclear p-NF2 levels decreased ( Figure 3C ). We also probed for MYPT-1 and detected it in the nuclear-enriched, but not in the cytosolic-enriched, fractions of heart homogenates and NRVMs ( Figure 3B and 3C), consistent with a recent report. 38 Subcellular fractionation of NRVMs into cytosolic and plasma membrane-enriched fractions revealed faintly detectable levels of NF2 at the plasma membrane, whereas p-NF2 was more evident (Online Figure IVC) .
NF2-Dependent Mst1 Localization
Because NF2 modified Mst1 activity, we investigated the subcellular localization of the Hippo pathway kinases large tumor suppressor kinase 2 (Lats2) and Mst1. Analysis of Lats2 Figure 1 . Oxidative stress-induced activation of NF2 is mediated by MYPT-1. A, NRVMs were treated with vehicle or H 2 O 2 (100 µmol/L) for the times indicated. Western blot analysis was performed to detect phosphorylated and total NF2 (Ser518) and Mst1 (Thr183). B and C, Quantification of responses at 30' time point, n=3. *, P<0.05. D, Wild-type C57BL/6 male mice were subjected to ischemia and reperfusion (30′/30′) or sham operation. Left ventricular homogenates were prepared and Western blot was performed to detect phosphorylated and total NF2 and Mst1. E and F, Quantitative analysis of results shown in D, n=4 mice per group. *, P<0.05. G, NRVMs were treated as described in A and Westerns were performed to detect phosphorylated and total MYPT-1 (Ser696). H, Quantification of response at 30′ time point, n=3. *, P<0.05. I, Wild-type C57BL/6 male mice were subject to sham or I/R as indicated in D and westerns were performed to detect phosphorylated and total MYPT-1. J, Quantification of results in I, n=3 mice per group. *, P<0.05. K, NRVMs were transfected with siRNA targeted to MYPT-1 or scrambled control siRNA. Seventy-two h later, cells were stimulated with H 2 O 2 (100 µmol/L) or vehicle for 1 h followed by Western blot analysis. Representative images of 3 independent experiments are shown. by guest on November 29, 2017 http://circres.ahajournals.org/
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subcellular distribution in cardiomyocytes demonstrated a robust nuclear presence ( Figure 3C ; Online Figure IVA and IVB). Mst1 showed a predominant cytosolic presence in NRVMs, adult mouse cardiomyocytes, and heart sections; however, after oxidative stress we observed a nuclear subpopulation of Mst1 ( Figure 3C ; Online Figure IVB) . Knockdown of either MYPT-1 or NF2 attenuated this response in NRVMs ( Figure 3C ). Furthermore, we observed an increase in Mst1 levels in nuclear-enriched fractions prepared from wild-type mouse myocardium subjected to I/R ( Figure 3D ). Nuclear localization of Mst1 was attenuated in hearts deficient for NF2, suggesting a causal role for NF2 in this process in vivo.
Association of NF2 With Hippo Pathway Components
Based on previous work demonstrating complexes comprised of NF2 and hippo in Drosophila 39 and NF2 and Lats in mammalian cells, 36 we examined whether NF2, Mst1, and Lats2 associate in cardiomyocytes. Co-immunoprecipitation studies showed an interaction between NF2 and Mst1 in hearts subjected to I/R ( Figure 3E ), and NRVMs subjected to oxidative stress (Online Figure VA) . We performed additional co-immunoprecipitation experiments, this time stimulating NRVMs with H 2 O 2 and using cytosolic and nuclear-enriched fractions to determine NF2 interactions. As demonstrated in Figure 3F , association between NF2 and MYPT-1, Mst1, and Lats2 was observed in nuclear-enriched fractions during oxidative stress. Phosphorylation status is important for NF2 conformation change and protein interactions. Therefore, we tested the ability of a phospho-resistant NF2 S518A mutant to associate with Mst1 and Lats2. Co-immunoprecipitation studies showed that NF2 S518A associated with Mst1 and Lats2, and to a greater extent than wild-type NF2, suggesting the importance of phosphorylation of Ser518 in modulating these protein associations (Online Figure VB) .
NF2 Deletion Attenuates Cardiac Injury Ex Vivo
To test the physiological role of NF2, we crossed NF2-floxed mice 29 with α-MHC-Cre transgenic mice 30 to generate cardiac-specific knockout (NF2 flox/flox ;Cre αMHC (NF2 CKO)) mice. These mice had depleted levels of NF2 protein in the myocardium but not in other tissues tested ( Figure 4A ). Hearts were isolated from NF2 CKO and control NF2 flox/flox mice and subjected to global ischemia and reperfusion ex vivo using the Langendorff preparation. We observed that NF2 CKO hearts had significantly smaller infarct regions compared with control NF2 flox/flox hearts ( Figure 4B and 4C). Cardiac function was assessed at baseline prior to ischemia and serially every 10 minutes through 1 hour of reperfusion. While no differences were observed at baseline, we found that NF2 CKO hearts had significantly improved cardiac function during reperfusion ( Figure 4D through 4G), whereas no significant difference in heart rate was observed ( Figure 4H ). Taken together, these data suggest that the disruption of NF2 in cardiomyocytes confers protection against global I/R and preserves heart function.
Deletion of NF2 Affords Cardioprotection Against I/R Injury
To determine whether the disruption of NF2 also conferred protection of the myocardium in vivo, we subjected NF2 CKO and control NF2 flox/flox mice to I/R and determined infarct size 24 hours later. We found no difference in the myocardial area at risk after I/R; however, infarct size was significantly reduced in NF2 CKO mice indicating that NF2 deletion is cardioprotective ( Figure 5A through 5C). We also subjected mice to I/R and examined heart function by echocardiography 2 weeks postinfarction. We observed that left ventricular ejection fraction (LVEF%) was significantly greater in NF2 CKO mice compared with controls ( Figure 5D ). Because NF2 regulates Hippo signaling in mouse liver 26 and brain, 27 we examined the activation of the conserved pathway components Mst1 and Yap. The phosphorylation of both Mst1 and Yap was increased in NF2 flox/flox hearts in response to I/R, indicating Hippo pathway activation. However, this response was significantly attenuated in NF2 CKO hearts ( Figure 5E through 5G). The activation of known cardioprotective targets AKT and ERK1/2 showed negligible differences between NF2 flox/flox and NF2 CKO hearts ( Figure 5E , 5H, and 5I). Consistent with these findings, we also observed Yap downregulation in NRVMs overexpressing NF2, and increased Yap levels in NRVMs treated with siRNA-targeting NF2 (Online Figure VI) .
Yap Activation is Upregulated in NF2 CKO Myocardium
Yap is a transcriptional cofactor and prosurvival signaling molecule in cardiomyocytes 9 ; therefore, we hypothesized that altered gene expression because of Yap modulation might explain the protective effect observed in NF2 CKO mice. We first tested whether established Yap target genes were altered after Yap modification in NRVMs. Overexpression of Yap in NRVMs caused a significant increase in mRNA levels of ctgf, cyr61, fgf2, and birc5 compared with LacZ control (Online Figure VIIA) . Conversely, shRNA-mediated knockdown of endogenous Yap significantly reduced Yap target gene expression (Online Figure VIIB) . To test whether NF2 affects Yap transcriptional activity in NRVMs, we used a TEAD luciferase reporter system and either overexpressed or silenced NF2, which resulted in a significant decrease and increase in reporter gene expression, respectively (Online Figure VIIC and VIID). We also examined the expression of these Yap targets 2) associates with mammalian sterile 20-like kinase 1 (Mst1) after oxidative stress. A, Confocal microscopy images of NRVMs. Endogenous NF2 (green) and troponin-T (red) were detected by immunofluorescence. Nuclei were stained with DAPI (4',6-diamidino-2-phenylindole). Scale bar, 10 µm. B, Cytosolic and nuclear-enriched fractions were prepared from ventricular homogenates of C57BL/6 wild-type mice and subjected to Western blot analysis. C, NRVMs were transduced with siRNA targeted to MYPT-1 (siMY), NF2 or scrambled control (siCTRL). Seventy-two h later, cells were treated with H 2 O 2 (100 µmol/L) or vehicle for 1 h. Cytosolic and nuclear-enriched fractions were prepared and subjected to western analysis. D, Control NF2 floxed (NF2 F/F ) and NF2 CKO mice were subjected to I/R (30'/30') or sham operation and ventricular homogenates were separated into cytosolic and nuclear-enriched fractions. GAPDH (glyceraldehyde 3-phosphate dehydrogenase) and Histone H3 were used as markers of cytosolic and nuclear fractions respectively. E, C57BL/6 wild-type mice were subjected to sham operation (S) or I/R (30'/30"). Homogenates were used for co-immunoprecipitation and subsequent Western blotting. F, NRVMs were treated with H 2 O 2 (100 µmol/L) or vehicle for 1 h. Cytosolic and nuclear-enriched fractions were prepared and subjected to immunoprecipitation using anti-NF2 antibody or control IgG. Immunocomplexes and inputs were analyzed by Western blot. Representative images of 3 to 4 independent experiments are shown. by guest on November 29, 2017 http://circres.ahajournals.org/
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by quantitative reverse transcription PCR and observed a significant upregulation of the aforementioned genes in NF2 CKO hearts compared with controls ( Figure 5J ). Taken together, these results suggest that Yap activates a genetic program in the heart similar to that observed in the liver 26 and brain, 27 and indicate that Yap activity is upregulated in hearts deficient for NF2.
Genetic Inhibition of Yap Abolishes the Protection Observed in NF2 CKO Mice
Finally, we tested whether Yap activity is required for the protective effect of NF2 depletion in vivo. ) mice were generated. The expected reduction in NF2 and Yap protein was confirmed by Western blot (Figure 6A ), and these mice were subjected to I/R. Consistent with our findings above, the NF2 CKO mice had significantly smaller infarcts and reduced TUNEL + staining compared with control mice ( Figure 6B , 6D, and 6E). There were no differences in area at risk/left ventricle between the groups ( Figure 6C 
Discussion
NF2 is a recognized tumor suppressor that has been shown to promote Hippo signaling in Drosophila. [23] [24] [25] Subsequent work has demonstrated that NF2 can modulate mammalian Hippo signaling in the murine liver 26 and brain. 27 In a recent report from Marian and colleagues, NF2 was shown to be activated in a mouse model of arrhythmogenic cardiomyopathy and in heart samples from arrhythmogenic cardiomyopathy patients. 28 Murine models of arrhythmogenic cardiomyopathy displayed increased activation of Hippo signaling and reduced Yap activation, which was shown to contribute to the observed increase in adipogenesis. However, prior to our study, a loss-of-function mouse had not been used to test whether NF2 regulates Hippo signaling and contributes to myocardial injury caused by I/R. We demonstrate here that NF2 is activated in cardiomyocytes and mouse myocardium in response to oxidative stress and I/R, and contributes to cardiac injury through the engagement of the Hippo pathway and subsequent inactivation of the transcriptional cofactor Yap.
Regulation of NF2 through multiple post-translational modifications has been demonstrated previously. NF2 is negatively regulated via Ser518 phosphorylation by PKA 18 and PAK2 16, 17 , which promotes its inactive conformation, and thereby attenuates downstream signaling. 15, 22 Alternatively, dephosphorylation of Ser518 mediated by MYPT-1 activates NF2 19 . NF2 function can also be modulated through Aktmediated phosphorylation at Thr230 and Ser315. 40 These Akt-dependent modifications both inhibited the association of NF2 with effectors while also eliciting increased ubiquitin-mediated NF2 degradation. Our study demonstrates that MYPT-1 associates with NF2 and promotes its dephosphorylation, indicating that MYPT-1 is an important promoter of NF2 activity in cardiomyocytes. MYPT-1 was also activated (as determined by regulatory phosphorylation at Thr696) after I/R; however, establishing evidence that MYPT-1 is required for NF2 activation in vivo is a limitation of this study and warrants further investigation. More recent work has demonstrated that NF2 is also a substrate of sumoylation. It was reported that SUMO-1 modification at Lys76 led to decreased active conformation status, altered subcellular localization, and impaired tumor suppressor function suggesting that sumoylation is important for proper NF2 signaling. ) and NF2 CKO mice were subjected to I/R (30'/24hr) and area at risk (AAR) and infarct size were determined by Alcian blue and TTC staining respectively. Whether NF2 is sumoylated in cardiomyocytes, and if this modification modulates NF2 activity in the heart, remains to be determined.
The subcellular localization of NF2 has been investigated in multiple cell types with varied observations. [34] [35] [36] [37] 42, 43 Recent findings from the Pan laboratory demonstrated that plasma membrane association of NF2 and direct binding with Lats1/2 is critical for engagement of Hippo signaling and subsequent inactivation of Yap. 36 In the other work, Li et al have demonstrated that NF2 can shuttle between the cytosol and nucleus, an observation that may be mediated by a nuclear localization motif present in the N-terminal portion of NF2. 44 It is likely that observed differences in subcellular localization of NF2 are due to cell-type specificity and that NF2 has important cellular functions in multiple locations. In NRVMs, adult mouse cardiomyocytes, and mouse heart sections, we observed NF2 in the cytosol and nucleus, and in relatively lower levels in the plasma membrane, using both biochemical fraction enrichment and immunofluorescence-based approaches. In contrast, p-NF2 was detected in cytosolic and nuclear fractions, with relative enrichment at the plasma membrane. Importantly, nuclear p-NF2 levels decreased after oxidative stress indicating that this is an important site of NF2 activation. We also observed a subpopulation of Mst1 in nuclear-enriched fractions of stressed cardiomyocytes and hearts, and Lats2 appeared almost exclusively nuclear, similar to our prior work. 8 The arrhythmogenic cardiomyopathy study mentioned above also examined the distribution of Hippo pathway components by immunostaining heart sections. 28 In mouse myocardium, p-NF2 was reported to localize to cardiomyocyte desmosomes. This is not inconsistent with our current findings, which demonstrate p-NF2 at the plasma membrane. It should be noted that this prior study did not observe the localization of p-Mst1 in the nucleus. It is possible that this apparent discrepancy concerning Mst1 is due to the type of stress imposed or the potential for heterogeneity between cardiomyocytes in the heart. Indeed, our NF2 staining results suggest that nuclear NF2 may be more pronounced in a select subset of cardiomyocytes. We think it is likely that NF2 serves important physiological functions in multiple subcellular regions. Based on our localization and immunoprecipitation results, we propose that the nucleus is one of perhaps several important focal points of NF2-Hippo signaling in the cardiomyocyte.
Our prior work demonstrated a deleterious role for Mst1 during I/R 4, 7 . These studies interrogated both upstream regulation and downstream effectors of Mst1 in this setting. We identified a K-Ras/RASSF1A/Mst1 complex present at mitochondria that mediated the activation of Mst1 at this subcellular locale. We also found that active Mst1 phosphorylates Bcl-xL, thereby attenuating Bcl-xL-Bax interaction and increasing Bax activation and cardiomyocyte apoptosis. 7 Importantly, we demonstrated that this noncanonical Hippo signaling (ie, not through Lats2/Yap) contributes to I/R injury. 45 Our current findings extend this work by demonstrating that NF2 is a regulator of canonical Hippo signaling in the myocardium and implicate the nucleus as a target organelle in which this signaling occurs. Based on our findings, we hypothesize that NF2 and K-Ras/RASSF1A function to activate Mst1 in separate subcellular locations (mitochondria versus nuclei) leading to the engagement of different downstream effectors (Bcl-xL versus Lats2/Yap). Mst1 has also been shown to inhibit cardiomyocyte autophagy and contribute to ischemic injury. 31 Although we found that NF2 promotes Mst1 activation, we did not observe a significant effect of NF2 on were generated. A, Ventricular homogenates from all groups were subjected to western analysis to determine levels of NF2 and Yap protein. B-D, All groups were subjected to I/R (30'/24hr) and infarct size and area at risk (AAR) determined by TTC and Alcian blue staining respectively. Scale bar, 1 mm. E, Representative images from TUNEL staining of heart sections after I/R (30'/24hr) are shown. Sections were counterstained with DAPI (blue) and troponin-T (green) to identify nuclei and cardiomyocytes, respectively (Merged). Scale bar, 50 μm. F, Average data as determined by TUNEL. *, P<0.05. N.S. indicates not significant. n=5 to 8 mice per group.
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cardiomyocyte autophagy (Online Figure VIII) , although further study is needed to examine this in greater detail. Taken together, we propose that the inhibition of Mst1 likely confers cardioprotection by preventing multiple signaling mechanisms and would be advantageous versus targeting a single pathway in isolation. Mst1 contains a regulatory phosphorylation site, Thr183, in its N-terminal catalytic domain. 46 Autophosphorylation of Thr183 has been shown to be important for Mst1 activation and homodimerization, the latter mediated by its C-terminal SARAH domain. 47 The SARAH domain also allows for heterodimerization between Mst1 and RASSF1A, NORE1 and Salvador, known activators of the kinase. Structural studies of Mst1 demonstrated the importance of h1 and h2 helices for homodimerization of Mst1 monomers 48 ; however, the precise molecular mechanism of Mst1 activation remains unclear and it is possible that additional kinases may play an important role. 49, 50 We observed an association between NF2 and MYPT-1, Mst1 and Lats2, and increased phosphorylation of Mst1 after oxidative stress. Our results lead us to speculate the formation of a nuclear complex that could include additional components (eg, Salvador, MOB1A/B, MAP4K/Happyhour). 51, 52 We hypothesize that the recruitment of Mst1 to this complex may be facilitated by Lats2, as a direct interaction between NF2 and Lats2 has been demonstrated previously. 36 Based on the literature regarding the function of Yap in the mammalian heart, it is not entirely surprising that ablation of a negative regulator of Yap activity, in this case NF2, would prove cardioprotective against I/R injury. Our previous work demonstrated that the inhibition of Lats2 in the myocardium afforded protection against I/R injury through increased YapFoxO1 transcriptional activation. 8 Through loss-of-function studies, Yap has been shown to be critical for adult heart homeostasis and protection against cardiomyocyte apoptosis, as well as a promoter of cardiomyocyte growth and proliferation. 9 ,53,54 Conversely, strategies to increase Yap expression and activity stimulate proliferation of cardiomyocytes and cardioprotection against myocardial infarction and resection of the neonatal mouse heart.
53,55 Our current study demonstrates that the cardioprotection observed in NF2 CKO mice is abrogated by Yap heterozygosity in cardiomyocytes. We think that this is compelling evidence that Yap functions downstream of NF2; however, we cannot exclude the possibility that Yap acts in a parallel pathway that supersedes the NF2 effect in this setting.
Our results indicate that NF2 is activated by oxidative stress and has a presence in the nuclei of cardiomyocytes where it promotes the activation of Mst1 and inhibitory phosphorylation of Yap (Figure 7 ). This work further supports the notion that increased Yap activity during acute stress/injury serves to protect the myocardium and highlights Yap as an attractive target for potential future therapies against myocardial infarction. What Is Known?
• Myocardial infarction results in cardiomyocyte loss and insufficient self-renewal, which contribute to injury and compromised heart function.
• Increasing evidence suggests that Hippo-Yap signaling can modulate cardiomyocyte death and proliferation in the postnatal heart. • NF2 has been linked to the Hippo-Yap pathway in mouse liver and brain, and is associated with arrhythmogenic cardiomyopathy in human and murine hearts.
What New Information Does This Article Contribute?
• NF2 interaction with Mst1 and Lats2 in the cardiomyocyte nucleus is associated with Mst1 activation after oxidative stress.
• Phosphorylated (inactive) NF2 is decreased in failing human hearts and after ischemia/reperfusion in mouse hearts.
• Cardiomyocyte-specific deletion of NF2 confers protection against ischemia/reperfusion injury in the mouse heart. • Yap transcriptional activity is upregulated in NF2 cardiomyocyte-specific knockout hearts, and evidence implicates heightened Yap function as a mediator of the observed cardioprotection.
Cardiomyocyte loss contributes to injury after myocardial infarction. The Hippo-Yap pathway has emerged as an important modulator of cardiomyocyte survival and proliferation, yet mechanisms that underlie signaling initiation remain incompletely understood. Inc.). The animals were kept warm with heat lamps. Rectal temperature was monitored and maintained between 36°C and 37°C. The heart was exposed by a thoracotomy through the 4 th and 5 th ribs. The left coronary artery was located and a suture was passed under the artery. To occlude the artery, a short length of tubing was threaded through the suture ends and occlusion was effected by placing tension on the suture such that the tube compressed the artery. Ischemia was confirmed by ECG change (ST elevation). After occlusion for 30 minutes, the silicon tubing was removed to achieve reperfusion, and the rib space and overlying muscles were closed in layers using 5.0 nylon sutures. For sham operation, the same protocol was followed; however, no ligation of the coronary artery was performed. Postoperatively, mice were administered Buprenex-SR (1.2 mg/kg) subcutaneously for analgesia. Mice were then allowed to recover under close monitoring in an incubator. During this time, mice were observed for signs of post-operative complications including pain, pneumothorax, and acute heart failure or sudden death.
Animals were housed in the Animal Facility in a climate-controlled environment.
Measurement of infarct size. Twenty-four hours after reperfusion, mice were reanesthetized and intubated, and the chest was opened. After the heart was arrested at the diastolic phase by KCl injection, the ascending aorta was cannulated and perfused with saline to wash out blood. The left anterior descending coronary artery was occluded with the same suture, which had been left at the site of the ligation. To demarcate the ischemic area at risk (AAR), Alcian blue dye (1%) was perfused into the aorta and coronary arteries. Hearts were excised, and LVs were sliced into 1-mm-thick cross sections, and incubated with a 1% triphenyltetrazolium chloride (TTC) solution at 37°C for 15 minutes.
The infarct area (pale), the AAR (not blue), and the total LV area from both sides of each LV pressures and LV dP/dt were recorded with a strip chart recorder (Astro-Med, Inc).
The LV end-diastolic pressure was set at 4-10 mmHg at the beginning of perfusion by adjusting the volume of the balloon in the LV and the volume was kept constant throughout an experiment. After a 30 min equilibration period, the heart was subjected to 30 min of global ischemia (at 37°C) followed by 60 min of reperfusion.
Echocardiography, Mice were anesthetized using 12 µl/g body weight of 2.5% tribromoethanol (Avertin, Sigma), and echocardiography was performed as described previously 5 , using a 13-MHz linear ultrasound transducer. Two-dimensional guided Mmode measurements of LV internal diameter were obtained from at least three beats and then averaged. LV end-diastolic dimension (LVEDD) was measured at the time of the apparent maximal LV diastolic dimension, and LV end-systolic dimension (LVESD) was measured at the time of the most anterior systolic excursion of the posterior wall. LVEF was calculated using the following formula:
Cell culture. Primary cultures of ventricular cardiomyocytes were prepared from 1-day-old Crl: (WI)BR-Wistar rats and maintained in culture as described previously 4 .
The phosphatase inhibitors okadaic acid and calyculin A were purchased from Calbiochem (EMD). Hydrogen peroxide was purchased from Sigma.
Adult mouse cardiomyocyte isolation. Myocytes were enzymatically isolated from mouse hearts as previously described 6 . Briefly, the hearts were removed from mice anesthetized with pentobarbital (65 mg/kg, i.p.), and were retrograde perfused at 37°C using a Langendorff-type apparatus with nominally Ca 2+ -free Tyrode's solution containing 0.5 mg/ml collagenase (Type II; Worthington) and 0.1 mg/ml protease (type XIV, Sigma) for 13-15 minutes. The enzyme solution was then washed out and the hearts were removed from the perfusion apparatus. Ventricles were placed in a petri dish, and gently teased apart with forceps. Finally, the myocytes were filtered through nylon mesh (200 µm) and used immediately for biochemical assays.
Adenoviral constructs.
Recombinant adenovirus vectors were constructed as described previously 7 . Briefly, pBHGloxΔE1,3Cre (Microbix), including the ΔE1 adenoviral genome, was co-transfected with the pDC316 shuttle vector containing the gene of interest into HEK293 cells. We made replication-defective human adenovirus type 5 (devoid of E1) harboring 3x FLAG-tag. Wild-type NF2 and S518A mutant NF2
were subcloned from Addgene plasmids #19699 and #19700 respectively. Plasmids were sequenced to confirm fidelity. Adenoviruses harboring Mst1, Dn-Mst1(K59R), 3x
FLAG-Yap and sh-Yap were generated as described previously 8, 9 . Adenovirus harboring beta-galactosidase (LacZ) was used as a control. Evaluation of apoptosis. DNA fragmentation was detected in cardiomyocytes using TUNEL (Roche) as described previously 5 . Nuclear density was determined by counting DAPI-stained nuclei in 20 different fields for each sample. For detection of TUNEL+ nuclei in vivo, heart sections were counterstained with Troponin-T to identify cardiomyocytes. TUNEL+ nuclei were assessed in the border zone region of the infarcted myocardium. For each heart, 20 different fields were chosen at random in this region.
Transfection and luciferase assays. Cardiomyocytes were transfected using Lipofectamine2000 reagent (Invitrogen) according to the manufacturer's instructions. A TEAD luciferase reporter gene (8xGTIIC-luciferase; Addgene plasmid #34615) was used to assess Yap activity. After transfection, cells were lysed with Passive Lysis Buffer (Promega), and transcriptional activity was measured using the luciferase assay system (Promega) with an OPTOCOMP I luminometer (MGM instruments).
qRT-PCR. RNA was isolated, cDNA was generated, and quantitative real-time PCR performed as described previously 7 . Primers used to detect rat transcripts were: Ctgf Glucose deprivation. To mimic a starvation condition and elicit autophagy, cardiomyocytes were washed three times with PBS and incubated in glucose-free serumfree DMEM (Invitrogen) at 37 °C as described 11 .
Human heart samples. The samples from explanted hearts used in this study were obtained from 4 patients who had received heart transplants and 4 age-matched donors at the Taipei Veterans General Hospital. The study was approved by the Institutional Ethics Committee (VGHIRB No.:2012-06-028D), and all patients or their family expressed their willingness to participate through an informed consent form.
Myocardial posterior wall samples were collected during preparation of donor hearts for transplantation in the hospital. Myocardial samples from near the mitral annulus were obtained from recipients at the time of therapeutic transplantation. Immediately after tissue procurement, the samples were stored in liquid nitrogen and kept at -80°C.
Statistics. All data are reported as mean ± SEM. Evaluation between three or more groups was done using one-way ANOVA. The statistical significance of the differences between groups was calculated using post hoc comparisons. 
